CSIMarket
 


X4 Pharmaceuticals Inc  (XFOR)
Other Ticker:  
 


X4 Pharmaceuticals Inc's EBITDA Margin by quarter

Trends, Rankings, Statistics



XFOR EBITDA Margin (Mar 31 2024)
I. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
III. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Revenue Change - - - - -
Seq. Revenue Change - - - - -
Revenue In Millions $0.00 $0.00 $0.00 $0.00 $0.00
EBITDA Margin - - - - -
EBITDA Margin Total Ranking # # # # #
EBITDA In Millions $-49.81 $-0.54 $-54.42 $-22.91 $-27.82
Y / Y EBITDA Change - - - - -
Seq. EBITDA Change - - - - -


Commenting First Quarter 2024 EBITDA Margin
X4 Pharmaceuticals Inc achived higher Operating Loss of -50 then a $-0.54 millions reported a quarter before.

Observing first quarter 2024 results within Biotechnology & Pharmaceuticals industry X4 Pharmaceuticals Inc has achieved highest EBITDA Margin. While overall EBITDA Margin ranking remained unchanged compare to previous quarter at no. .
Learn about Operating Margin
XFOR's EBITDA Margin first quarter 2024 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall # 0

EBITDA Margin Statistics
High Average Low
0 % 0 % 0 %
 




Other EBITDA Margin Profitability Ratios
XFOR's Cumulative EBITDA Margin
Biotechnology & Pharmaceuticals Industry EBITDA Margin Trends and Statistics
Healthcare Sector EBITDA Margin Statistics
EBITDA Margin Profitability Trends for overall market
XFOR's EBITDA Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking EBITDA Margin
Lowest Ranking EBITDA Margin
EBITDA Margin Profit Margin for XFOR's Competitors
EBITDA Margin Profit Margin for X4 Pharmaceuticals Inc's Suppliers
EBITDA Margin Profit Margin for XFOR's Customers

You may also want to know
XFOR's Annual Growth Rates XFOR's Profitability Ratios XFOR's Asset Turnover Ratio XFOR's Dividend Growth
XFOR's Roe XFOR's Valuation Ratios XFOR's Financial Strength Ratios XFOR's EBITDA Growth
XFOR's Roa XFOR's Inventory Turnover Ratio XFOR's Growth Rates XFOR's Dividend Comparisons


Companies with similar EBITDA Margin in the quarter ending Mar 31 2024, within Biotechnology & Pharmaceuticals Industry EBITDA MarginMar 31 2024 MRQ EBITDAMar 31 2024 MRQ Revenue




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com